Incidence and Risk Factors of Chest Wall Metastasis at Biopsy Sites in Patients with Malignant Pleural Mesothelioma
Cancers 2022 September 7 [Link] Masaki Hashimoto, Michiko Yuki, Kazuhiro Kitajima, Akihiro Fukuda, Toru Nakamichi, Akifumi Nakamura, Ayumi Kuroda, Seiji Matsumoto, Nobuyuki Kondo, Ayuko Sato, Koichiro Yamakado, Tohru Tsujimura, Seiki Hasegawa Abstract To investigate the incidence and risk factors of chest wall metastasis (CWM) at biopsy sites in patients with malignant pleural mesothelioma (MPM). This…Read More
The association between pleural fluid exposure and survival in pleural mesothelioma
Chest 2021 June 10 [Link] Rachelle Asciak, Nikolaos I Kanellakis, Anna Bibby, Andrew Kidd, Stephen Gerry, Rachel Mercer, Nick Maskell, Kevin G Blyth, Peter Fsadni, Stephen Montefort, Ioannis Psallidas, Najib M Rahman Abstract Background: Most patients with malignant pleural mesothelioma (MPM) present with malignant pleural effusion (MPE). There is in vitro evidence that MPE may…Read More
Predictors of outcome of pleurodesis in patients with malignant pleural effusion: a systematic review and meta-analysis.
Expert Review of Respiratory Medicine 2020 March 26 [Link] Hassan M, Gadallah M, Mercer RM, Harriss E, Rahman NM Abstract Objectives: Pleurodesis is an important management option to palliate breathlessness in patients with malignant pleural effusion (MPE). This systematic review aimed to examine available literature for studies investigating factors that predict pleurodesis outcome.Methods: The healthcare…Read More
First-ever Abscopal Effect after Palliative Radiotherapy and Immuno-gene Therapy for Malignant Pleural Mesothelioma.
Cureus 2019 February 20 [Link] Barsky AR, Cengel KA, Katz SI, Sterman DH, Simone CB Abstract Malignant pleural mesothelioma (MPM) is a highly aggressive disease, with few, if any, curative interventions. While there is growing interest in using immunotherapy and immuno-gene therapy to treat MPM, very limited data currently exist for combining these modalities with…Read More
Fluorodeoxyglucose versus Choline Positron Emission Tomography/Computed Tomography Response Evaluation in Two Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and Neoadjuvant Chemotherapy.
Cureus 2018 November 28 [Link] Kitajima K, Nakamichi T, Hasegawa S, Kuribayashi K, Yamakado K Abstract Talc pleurodesis has been reported to increase fluorodeoxyglucose (FDG) uptake in the high attenuation areas of pleural thickening, making it difficult to distinguish between benign granulomatous inflammatory processes and malignancies, which may therefore interfere with the post-chemotherapy disease evaluation…Read More
Video-assisted thoracoscopic PlasmaJet ablation for malignant pleural mesothelioma.
Journal of visualized surgery 2018 March [Link] Perikleous P, Asadi N, Anikin V Abstract The role of surgery in malignant pleural mesothelioma (MPM) remains debatable; nonetheless the relative advantages of different surgical approaches are frequently reassessed and reconsidered. While extensive operations and longer recovery periods can be justified for a group of carefully selected patients,…Read More
Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: a multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural catheters
BMJ Open 2016 July 5 [Epub ahead of print] [Link] Azzopardi M, Thomas R, Muruganandan S, Lam DC, Garske LA, Kwan BC, Rashid Ali MR, Nguyen PT, Yap E, Horwood FC, Ritchie AJ, Bint M, Tobin CL, Shrestha R, Piccolo F, De Chaneet CC, Creaney J, Newton RU, Hendrie D, Murray K, Read CA, Feller-Kopman…Read More
Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival
Anticancer Research. 2012 Nov;32(11):5071-4. [Link] Lumachi F, Mazza F, Ermani M, Chiara GB, Basso SM. Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University of Padua, School of Medicine, Via Giustiniani 2, 35128 Padova, Italy. email@example.com. Abstract Malignant pleural effusion (MPE) is common in most patients with advanced cancer, especially in those with lung cancer,…Read More
Improved quality of life in patients with malignant pleural effusion following videoassisted thoracoscopic talc pleurodesis. Preliminary results
Anticancer Research. 2012 Nov;32(11):5131-4. [Link] Basso SM, Mazza F, Marzano B, Santeufemia DA, Chiara GB, Lumachi F. Surgey I, S. Maria degli Angeli Hospital, Via Montereale 24, 33170 Pordenone, Italy. firstname.lastname@example.org. Abstract Malignant pleural effusion (MPE) is a common, debilitating complication of several types of advanced malignancy, which may significantly reduce the quality of life…Read More
Medical thoracoscopic talc pleurodesis for malignant pleural effusion: an analysis of 27 cases
Beijing Da Xue Xue Bao. 2008 Dec 18;40(6):600-2. [Article in Chinese] [Link] Zhang W, Wang GF, Zhang H, Mu XD, Jin Z. Department of Respiratory Medicine, Peking University First Hospital, Beijing, China. Abstract Objective: To evaluate the efficacy and safety of talc poudrage pleurodesis via semi-rigid medical thoracoscopy in the treatment of malignant pleural effusions,…Read More